AMRC

Ameresco, Inc. NYSE

Industrials ·Engineering & Construction ·US · ameresco.com

$31.48

After hrs $30.77 -0.02%

Mkt Cap $1.7B

52w Low $11.48 59.8% of range 52w High $44.93

50d MA $27.36 200d MA $29.66

P/E (TTM) 37.3x

EV/EBITDA 14.9x

P/B 1.5x

Debt/Equity 1.8x

ROE 5.5%

P/FCF -3.5x

RSI (14) —

ATR (14) —

Beta 2.61

50d MA $27.36

200d MA $29.66

Avg Volume 521.8K

About

Ameresco, Inc., a clean technology integrator, provides a portfolio of energy efficiency and renewable energy supply solutions in the United States, Canada, and internationally. It offers energy efficiency, infrastructure upgrades, energy security and resilience, asset sustainability, and renewable energy solutions for businesses and organizations. The company operates through U.S. Regions, U.S. F…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 4, 2026	AMC	-0.27	-0.33	-22.2%	—	—	—	—	—	—	—	—
Mar 2, 2026	AMC	0.32	0.39	+21.9%	30.95	+0.2%	-9.9%	-9.0%	-12.3%	-17.0%	-15.2%	—
Nov 3, 2025	AMC	0.26	0.35	+34.6%	40.00	-8.5%	-9.3%	-6.4%	-8.5%	-11.8%	-10.2%	—
Aug 4, 2025	AMC	0.06	0.27	+350.0%	16.70	+29.6%	+49.0%	+22.0%	+19.8%	+20.4%	+17.2%	—
May 5, 2025	AMC	-0.26	-0.11	+57.7%	11.63	+20.4%	+11.8%	+8.9%	+13.4%	+14.9%	+25.1%	—
Feb 27, 2025	AMC	0.76	0.88	+15.8%	18.33	-11.1%	-35.6%	-42.4%	-47.7%	-45.8%	-49.3%	—
Nov 7, 2024	AMC	0.47	0.33	-29.8%	31.64	+1.1%	-16.3%	-9.6%	-16.4%	-16.9%	-15.4%	—
Aug 5, 2024	AMC	0.26	0.09	-65.4%	26.85	-0.9%	+7.0%	+4.0%	+7.8%	-0.5%	-0.6%	—
May 7, 2024	AMC	-0.11	-0.10	+9.1%	22.24	+7.0%	+21.1%	+25.7%	+24.2%	+28.4%	+34.8%	—
Feb 28, 2024	AMC	0.57	0.69	+21.1%	20.37	+12.4%	+2.9%	-4.1%	-11.1%	-9.3%	-3.7%	—
Nov 6, 2023	AMC	0.46	0.40	-13.0%	26.61	-19.0%	-14.9%	-18.4%	-14.6%	-16.2%	-15.4%	—
Jul 31, 2023	AMC	0.18	0.15	-16.7%	58.21	-3.3%	-9.5%	-12.0%	-10.6%	-14.1%	-11.8%	—
May 1, 2023	AMC	0.03	0.03	-9.9%	40.78	+9.4%	+10.0%	+3.7%	+1.3%	+5.5%	+3.9%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 13	UBS	Maintains	Neutral → Neutral	—	$26.28	$26.26	-0.1%	-6.0%	-2.6%	-0.6%	+1.5%	+2.1%
Mar 11	Stifel	Maintains	Buy → Buy	—	$26.36	$26.51	+0.6%	-2.0%	-0.3%	-6.3%	-2.9%	-0.9%
Mar 4	B. Riley Securities	Maintains	Buy → Buy	—	$27.90	$28.73	+3.0%	+0.9%	-2.7%	-7.9%	-5.9%	-5.5%
Mar 3	Canaccord Genuity	Maintains	Buy → Buy	—	$30.95	$31.00	+0.2%	-9.9%	-9.0%	-12.3%	-17.0%	-15.2%
Dec 3	UBS	Maintains	Neutral → Neutral	—	$35.07	$35.28	+0.6%	-0.3%	-2.9%	-5.2%	-7.3%	-7.9%
Nov 14	Stifel	Maintains	Buy → Buy	—	$31.52	$31.49	-0.1%	+2.0%	-1.4%	-1.2%	-1.6%	-3.2%
Nov 3	Roth Capital	Maintains	Buy → Buy	—	$39.52	$39.62	+0.3%	+1.2%	-8.2%	-5.3%	-7.4%	-10.8%
Oct 31	B. Riley Securities	Maintains	Buy → Buy	—	$38.97	$39.38	+1.1%	+1.4%	+2.6%	-6.9%	-3.9%	-6.1%
Sep 25	Jefferies	Upgrade	Hold → Buy	—	$31.61	$32.61	+3.2%	+10.2%	+10.1%	+8.1%	+6.2%	+18.8%
Sep 10	B. Riley Securities	Maintains	Buy → Buy	—	$24.87	$26.05	+4.7%	+12.7%	+9.9%	+10.1%	+15.8%	+14.1%
Sep 2	Baird	Upgrade	Neutral → Outperform	—	$25.43	$26.43	+3.9%	+0.1%	+0.9%	+2.2%	+2.0%	-4.6%
Aug 18	UBS	Upgrade	Sell → Neutral	—	$21.43	$22.15	+3.4%	+6.3%	+5.0%	+5.6%	+6.0%	+13.7%
Jul 23	Jefferies	Maintains	Hold → Hold	—	$19.24	$19.52	+1.5%	+1.9%	-2.4%	-5.8%	-6.9%	-7.1%
Jun 3	UBS	Maintains	Sell → Sell	—	$13.53	$13.70	+1.3%	+13.3%	+9.6%	+9.8%	+14.6%	+18.0%
May 12	Stifel	Maintains	Buy → Buy	—	$13.36	$14.01	+4.9%	+8.9%	+9.1%	+6.4%	+10.5%	+12.0%
May 6	Piper Sandler	Maintains	Overweight → Overweight	—	$11.63	$14.00	+20.4%	+11.8%	+8.9%	+13.4%	+14.9%	+25.1%
May 6	Canaccord Genuity	Maintains	Buy → Buy	—	$11.63	$14.00	+20.4%	+11.8%	+8.9%	+13.4%	+14.9%	+25.1%
Apr 15	Baird	Downgrade	Outperform → Neutral	—	$10.09	$9.73	-3.6%	-5.1%	+1.0%	-1.4%	-14.2%	-4.1%
Mar 5	Stifel	Maintains	Buy → Buy	—	$9.59	$9.76	+1.8%	+3.5%	-3.1%	+15.6%	+7.8%	+7.6%
Mar 4	UBS	Downgrade	Buy → Sell	—	$10.56	$10.04	-4.9%	-9.2%	-6.0%	-12.0%	+5.0%	-2.1%
Feb 28	Baird	Maintains	Outperform → Outperform	—	$18.33	$16.29	-11.1%	-35.6%	-42.4%	-47.7%	-45.8%	-49.3%
Feb 28	Canaccord Genuity	Maintains	Buy → Buy	—	$18.33	$16.29	-11.1%	-35.6%	-42.4%	-47.7%	-45.8%	-49.3%
Feb 26	UBS	Maintains	Buy → Buy	—	$18.39	$18.37	-0.1%	-0.8%	-0.3%	-35.8%	-42.6%	-47.9%
Nov 11	Stifel	Maintains	Buy → Buy	—	$26.48	$27.45	+3.7%	+8.0%	-0.1%	-0.8%	+1.1%	-3.7%
Oct 22	Piper Sandler	Maintains	Overweight → Overweight	—	$30.74	$30.91	+0.6%	-2.5%	+0.1%	+2.7%	-0.7%	+3.3%
Sep 23	Baird	Maintains	Outperform → Outperform	—	$36.07	$38.70	+7.3%	+4.8%	+4.7%	+0.9%	+7.5%	+7.0%
Sep 5	UBS	Maintains	Buy → Buy	—	$29.29	$30.11	+2.8%	+8.0%	+0.4%	+2.7%	+4.4%	+13.6%
Aug 27	Baird	Maintains	Outperform → Outperform	—	$30.09	$30.23	+0.5%	-1.6%	-3.7%	-0.4%	+1.2%	-1.9%
Aug 6	Piper Sandler	Maintains	Overweight → Overweight	—	$26.85	$26.62	-0.9%	+7.0%	+4.0%	+7.8%	-0.5%	-0.6%
Jul 22	Piper Sandler	Maintains	Overweight → Overweight	—	$31.51	$33.32	+5.7%	+4.1%	+2.6%	-0.0%	+2.5%	-2.0%
May 14	UBS	Maintains	Buy → Buy	—	$28.56	$29.86	+4.6%	+5.0%	-1.8%	-4.1%	-4.2%	-2.2%
May 9	Stifel	Maintains	Buy → Buy	—	$26.94	$27.00	+0.2%	+3.8%	+2.5%	+6.0%	+11.3%	+4.1%
May 9	Baird	Maintains	Outperform → Outperform	—	$26.94	$27.00	+0.2%	+3.8%	+2.5%	+6.0%	+11.3%	+4.1%
Apr 22	Truist	Maintains	Buy → Buy	—	$18.80	$18.98	+1.0%	+1.5%	+11.1%	+13.2%	+11.6%	+14.3%
Apr 17	Oppenheimer	Maintains	Perform → Perform	—	$19.44	$19.62	+0.9%	-4.3%	-4.5%	-3.3%	-1.8%	+7.5%
Apr 11	Piper Sandler	Maintains	Overweight → Overweight	—	$23.12	$22.82	-1.3%	-2.1%	-9.5%	-13.1%	-15.9%	-19.5%
Apr 3	Raymond James	Maintains	Outperform → Outperform	—	$23.86	$23.49	-1.6%	-1.6%	-4.5%	-5.7%	-4.0%	+1.1%
Mar 12	Exane BNP Paribas	Upgrade	Neutral → Outperform	—	$21.32	$22.01	+3.2%	-2.4%	-3.3%	-5.3%	-0.3%	-1.5%
Mar 5	Piper Sandler	Maintains	Overweight → Overweight	—	$18.11	$18.00	-0.6%	+2.0%	+8.3%	+12.1%	+16.7%	+17.7%
Feb 29	Canaccord Genuity	Maintains	Buy → Buy	—	$20.37	$22.90	+12.4%	+2.9%	-4.1%	-11.1%	-9.3%	-3.7%
Feb 5	B. Riley Securities	Maintains	Buy → Buy	—	$21.10	$20.27	-3.9%	-4.2%	+1.9%	+4.0%	+6.1%	+8.3%
Dec 15	BofA Securities	Downgrade	Buy → Neutral	—	$36.52	$36.28	-0.7%	-7.3%	-12.3%	-9.5%	-16.0%	-13.9%
Nov 8	Stifel	Maintains	Buy → Buy	—	$22.65	$23.06	+1.8%	-4.2%	+0.3%	-1.6%	-0.6%	+19.9%
Nov 7	William Blair	Downgrade	Outperform → Market Perform	—	$26.61	$21.55	-19.0%	-14.9%	-18.4%	-14.6%	-16.2%	-15.4%
Nov 7	Oppenheimer	Downgrade	Outperform → Perform	—	$26.61	$21.55	-19.0%	-14.9%	-18.4%	-14.6%	-16.2%	-15.4%
Nov 7	Raymond James	Maintains	Outperform → Outperform	—	$26.61	$21.55	-19.0%	-14.9%	-18.4%	-14.6%	-16.2%	-15.4%
Oct 25	Roth MKM	Upgrade	Neutral → Buy	—	$29.73	$30.36	+2.1%	-5.8%	-7.6%	-8.3%	-7.1%	-12.0%
Oct 12	Oppenheimer	Maintains	Outperform → Outperform	—	$35.50	$34.60	-2.5%	-6.0%	-6.2%	-3.2%	-2.3%	-7.3%
Oct 6	Piper Sandler	Maintains	Overweight → Overweight	—	$33.09	$32.52	-1.7%	+0.3%	-1.6%	+8.2%	+7.3%	+0.8%
Oct 3	Raymond James	Maintains	Outperform → Outperform	—	$35.41	$34.99	-1.2%	-4.5%	-0.5%	-6.6%	-6.3%	-8.0%

Recent Filings

8-K · 1.01 !! High

Ameresco, Inc. -- 8-K 1.01: Material Agreement

Ameresco contributes its biogas business to a joint venture in exchange for 70% equity stakes, while AMRC Biogas HoldCo participates, potentially diversifying Ameresco's renewable energy portfolio and creating partnership opportunities.

May 4

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

Uncertainty regarding leadership transition at these financial institutions effective April 1, 2026, could trigger stock volatility as investors assess whether successor maintains current strategic direction and operational performance.

Mar 31

8-K

Unknown — 8-K Filing

IMSR's NRC design acceptance and DOE selection validates its commercial viability, potentially accelerating deployment timelines and reducing regulatory risk—crucial milestones justifying the $292 million investment for investors betting on advanced nuclear technology.

Mar 30

8-K

Ameresco, Inc. -- 8-K Filing

Ameresco reported fourth quarter 2025 financial results, providing investors updated performance metrics for the energy infrastructure solutions provider.

Mar 2

Data updated apr 24, 2026 5:55pm · Source: massive.com